Submission of Intimation of appointment of CFO.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has resubmitted an intimation regarding the appointment of Mrs. Bhoomika Choudhary as the Chief Financial Officer of the company, effective February 12, 2025. The board had approved her appointment in a meeting held on the same day. This filing is a correction to the original announcement, submitted to provide Mrs. Choudhary's brief profile as required under SEBI's disclosure norms, which was inadvertently omitted earlier. Mrs. Choudhary is a Post Graduate in Commerce from Rajasthan University with over three years of experience in accounting and finance and is not related to any existing directors, KMPs, or promoters.
This is a routine compliance filing and a back-ended disclosure of a CFO appointment already in effect since February 2025. It is unlikely to have any material impact on the stock price or shareholder value, though it does indicate the company is rectifying a past disclosure lapse.